(Q74185572)

English

Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer

scientific article published on 01 February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

A Pelegrin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Faurous

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Robert

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J C Saccavini

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D Guerreau

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J F Rossi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Fabbro

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Buchegger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J P Mach

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J C Artus

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

75

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

615-619

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980209%2975%3A4%3C615%3A%3AAID-IJC20%3E3.0.CO%3B2-6

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19980209)75:4<615::AID-IJC20>3.0.CO;2-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9466665%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74185572&oldid=2104449100"